홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
MLTX
#2018
MoonLake Immunotherapeutics Class A Ordinary Shares
17.510
0
-0.68%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-0.68%
월간 변동
+7.49%
6달 변화
+83.16%
년간 변동율
+83.16%
이전 종가
17.630
0
Open
17.510
0
Bid
Ask
Low
17.510
0
High
17.510
0
양
76
마켓
주식
헬스케어
MLTX
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
63.06 M
63.28 M
63.47 M
63.5 M
63.7 M
71.73 M
—
Valuation ratios
Enterprise value
9.3 B
10.22 B
7.26 B
8.79 B
1.03 B
2.5 B
19.59 B
Price to earnings ratio
-40.02
-28.65
-16.99
-16.98
-2.16
-3.73
-39.86
Price to sales ratio
7 512.11
-80.7 K
-12.32 K
13.78 K
889.04
1 418.42
3 765.23
Price to cash flow ratio
-15.87
-29.2
-7.78
-14.57
-9.32
4.33
-27.34
Price to book ratio
1.45
7.62
1.32
1.75
0.3
2.79
6.17
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.07
-0.4
0.08
0.12
0.17
0.15
0.51
Return on equity %
-0.07
-0.42
0.1
0.15
0.24
0.21
0.7
Return on invested capital %
-774.68
-4 018
753.51
875.86
762.97
583.45
2 975.79
Gross margin %
100
100
100
100
100
100
400
Operating margin %
161.19 K
140.68 K
135.67 K
16.06 K
26.75 K
-80.51 K
97.97 K
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
132.32 K
114.32 K
114.13 K
14.61 K
26.12 K
-77.07 K
77.78 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
25.51
21.11
21.11
16.65
8.5
9.27
55.53
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
-0
-0
0
0
0
-0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
0.14
0.16
0.18
0.17
0.65
Long term debt to total equity ratio
—
—
0.18
0.21
0.26
0.24
0.89
Per share metrics
Operating cash flow per share
-1.76
-2.94
0.6
0.86
0.7
0.91
3.08
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
7.85
7.13
7.59
6.72
6
6.11
26.43
Net current asset value per share
8.15
7.54
8.01
7.2
6.49
6.54
28.23
Tangible book value per share
7.77
7.11
6.44
5.59
4.56
4.72
21.32
Working capital per share
7.83
7.19
7.63
6.77
5.73
5.84
25.95
Book value per share
7.76
7.11
6.44
5.59
4.56
4.72
21.32
뉴스
MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal (NASDAQ:MLTX)
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day - Slideshow (NASDAQ:MLTX) 2026-02-23
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript
문레이크, 긍정적 axSpA 임상 데이터에 주가 급등
MoonLake stock surges on positive axSpA trial data
문레이크, InvestingPro 공정가치 분석 후 63% 급등
MoonLake stock surges 63% after InvestingPro Fair Value call
문레이크, 2상 축성 척추관절염 데이터 긍정적 발표
MoonLake reports positive phase 2 axial spondyloarthritis data
ImageneBio appoints Dr. Porter-Brown as Chief Medical Officer
문레이크 이뮤노테라퓨틱스, 데이터 발표 앞두고 BTIG ’매수’ 등급 재확인
BTIG reiterates Buy rating on Moonlake Immunotherapeutics stock ahead of data